KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Medpace Holdings (MEDP) Operating Expenses: 2015-2024

Historic Operating Expenses for Medpace Holdings (MEDP) over the last 10 years, with Dec 2024 value amounting to $1.7 billion.

  • Medpace Holdings' Operating Expenses rose 23.05% to $518.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.9 billion, marking a year-over-year increase of 11.39%. This contributed to the annual value of $1.7 billion for FY2024, which is 7.31% up from last year.
  • As of FY2024, Medpace Holdings' Operating Expenses stood at $1.7 billion, which was up 7.31% from $1.5 billion recorded in FY2023.
  • In the past 5 years, Medpace Holdings' Operating Expenses registered a high of $1.7 billion during FY2024, and its lowest value of $758.9 million during FY2020.
  • For the 3-year period, Medpace Holdings' Operating Expenses averaged around $1.5 billion, with its median value being $1.5 billion (2023).
  • Data for Medpace Holdings' Operating Expenses shows a peak YoY spiked of 31.13% (in 2023) over the last 5 years.
  • Yearly analysis of 5 years shows Medpace Holdings' Operating Expenses stood at $758.9 million in 2020, then climbed by 24.36% to $943.8 million in 2021, then increased by 25.17% to $1.2 billion in 2022, then surged by 31.13% to $1.5 billion in 2023, then rose by 7.31% to $1.7 billion in 2024.